Cargando…
Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword?
Accumulating evidence suggests that myeloid-derived suppressor cells (MDSCs) underpin an immunological checkpoint that is activated during inflammation or “inflammatory-like” conditions like cancer. Here, we discuss the identification of MDSCs in patients receiving allogeneic hematopoietic stem cell...
Autores principales: | Le Blanc, Katarina, Jitschin, Regina, Mougiakakos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782166/ https://www.ncbi.nlm.nih.gov/pubmed/24073377 http://dx.doi.org/10.4161/onci.25009 |
Ejemplares similares
-
Autophagy, a double-edged sword in hepatocarcinogenesis
por: Tian, Yongjun, et al.
Publicado: (2015) -
The double-edge sword effect of anti-CD73 cancer therapy
por: Stagg, John
Publicado: (2012) -
Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword
por: Zambirinis, Constantinos P., et al.
Publicado: (2013) -
Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013) -
Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)